GRANT-HUERTA YANINA (Chief Accounting Officer) sold 5.1% of their position (1.80K shares) of ATARA BIOTHERAPEUTICS, INC. on the open market
Open‑market sale worth $23.8K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 11/19/2025ACC: 0000905148-25-004140
Officer· Chief Accounting Officer
Since Mar 2026
-1.80K
Net shares
Net seller
$23.8K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
1.80K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−1.65K
Price / share
$13.19
Trade value
$21.69K
% of position
4.7%
11/17/2025
35.26K→33.61K
Common Stock
Direct
Shares
−85.00
Price / share
$13.19
Trade value
$1.12K
% of position
0.3%
11/17/2025
33.61K→33.53K
Common Stock
Direct
Shares
−74.00
Price / share
$13.19
Trade value
$976.13
% of position
0.2%
11/17/2025
33.53K→33.45K
Total
Net shares
−1.80K
Net value
-$23.79K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/17/2025 | S · Sale | −1.65K | $13.19 | $21.69K | 4.7% | 35.26K | 33.61K |
| Common Stock Direct | 11/17/2025 | S · Sale | −85.00 | $13.19 | $1.12K | 0.3% | 33.61K | 33.53K |
| Common Stock Direct | 11/17/2025 | S · Sale | −74.00 | $13.19 | $976.13 | 0.2% | 33.53K | 33.45K |
| Total | −1.80K | -$23.79K | ||||||
Derivative Transactions0
No derivative transactions reported